Patient’s Guide in Colorectal Cancer: Observation After Treatment and Treatment of Relapse
Surgery is a first-line treatment in up to 80% of patients with newly diagnosed colorectal cancer (CRC), as in most cases they present locoregional disease spread. Most patients undergo follow-up after treatment, in purpose to detect relapse and/or existence of metachronous lesions. Other benefits of surveillance are monitoring for side effects of therapy, detection of other comorbidities, as well as the psychological aspect of prolonged medical care. However, follow-up strongly depends on stage as well as perioperative treatment, and its intensity remains a matter of great controversy worldwide. In this section we will present a general review of different surveillance strategies regarding the role of endoscopic examination, diagnostic-imaging techniques, as well as fecal and serum tests in post-CRC surveillance. Presented recommendations do not include a matter of surveillance in patients with familial cancer syndromes that have not undergone total proctocolectomy.
KeywordsColorectal cancer Adenoma Surveillance Proctocolectomy Risk of relapse Colonoscopy Radiotherapy Chemotherapy
Computed tomographic colonography
European Society for Medical Oncology
Magnetic resonance imaging
Positron emission tomography
Our cordial thanks to the leading editor of this book, Prof. Jakub Fichna, for the invitation to cooperate in the drafting of this publication.
- 3.Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012;23(10):2479–516.CrossRefPubMedGoogle Scholar
- 6.Kahi CJ, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Robertson DJ, Rex DK, United States Multi-Society Task Force on Colorectal Cancer. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2016;150(3):758–768.e11.CrossRefPubMedGoogle Scholar
- 7.Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, Petrelli NJ, Ryan K, Schrag DH, Wong SL, Benson AB III, American Society of Clinical Oncology. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–70.CrossRefPubMedGoogle Scholar
- 8.Steele SR, Chang GJ, Hendren S, Weiser M, Irani J, Buie WD, Rafferty JF, Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. Practice guideline for the surveillance of patients after curative treatment of colon and rectal cancer. Dis Colon Rectum. 2015;58(8):713–25.CrossRefPubMedGoogle Scholar
- 9.National Institute for Health and Care Excellence guidelines: Colorectal cancer: diagnosis and management. https://www.nice.org.uk/guidance/cg131.
- 14.Rosati G, Ambrosini G, Barni S, Andreoni B, Corradini G, Luchena G, Daniele B, Gaion F, Oliverio G, Duro M, Martignoni G, Pinna N, Sozzi P, Pancera G, Solina G, Pavia G, Pignata S, Johnson F, Labianca R, Apolone G, Zaniboni A, Monteforte M, Negri E, Torri V, Mosconi P, Fossati R, GILDA working group. A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma. Ann Oncol. 2016;27(2):274–80.CrossRefPubMedGoogle Scholar
- 15.Lepage C, Phelip JM, Cany L, Faroux R, Manfredi S, Ain JF, Pezet D, Baconnier M, Deguiral P, Terrebone E, Adenis A, Le Malicot K, Bedenne L, Bouché O. Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial. Dig Liver Dis. 2015;47(7):529–31.CrossRefPubMedGoogle Scholar
- 18.Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–60.CrossRefPubMedGoogle Scholar
- 20.Hong YS, Nam BH, Kim KP, Lee JL, Park JO, Park YS, et al. Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) for rectal cancer patients whose postoperative yp stage 2 or 3 after preoperative chemoradiotherapy: updated results of 3-year disease-free survival from a randomized phase II study (The ADORE). J Clin Oncol. 2014;32(15_suppl):3502.Google Scholar
- 21.Potemski P, Polkowski W, Bujko K, Didkowska J, Guzel Z, Herman R, Łacko A, Olszewski W, Pałucki J, Reguła J. Nowotwory przewodu pokarmowego; 2011. p. 333. Translated from German original: Diagnosis and therapy of gastrointestinal tumors, edition 2011; the translation is published by arrangement with Nora-Verlag GmbH.Google Scholar